Search Results
Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, People’s Republic of China
Search for other papers by Wenpeng Dong in
Google Scholar
PubMed
Search for other papers by Ye Jia in
Google Scholar
PubMed
Search for other papers by Xiuxia Liu in
Google Scholar
PubMed
Search for other papers by Huan Zhang in
Google Scholar
PubMed
Search for other papers by Tie Li in
Google Scholar
PubMed
Search for other papers by Wenlin Huang in
Google Scholar
PubMed
Search for other papers by Xudong Chen in
Google Scholar
PubMed
Search for other papers by Fuchun Wang in
Google Scholar
PubMed
Search for other papers by Weixia Sun in
Google Scholar
PubMed
Department of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin, People’s Republic of China
Search for other papers by Hao Wu in
Google Scholar
PubMed
Introduction As one of the long-term complications of diabetes, diabetic nephropathy (DN) is the main cause of end-stage renal disease ( Dronavalli et al . 2008 ). Thus, end-stage renal disease cannot be effectively prevented or treated
Search for other papers by Kanta Kon in
Google Scholar
PubMed
Search for other papers by Hiroshi Tsuneki in
Google Scholar
PubMed
Search for other papers by Hisakatsu Ito in
Google Scholar
PubMed
Search for other papers by Yoshinori Takemura in
Google Scholar
PubMed
Search for other papers by Kiyofumi Sato in
Google Scholar
PubMed
Search for other papers by Mitsuaki Yamazaki in
Google Scholar
PubMed
Search for other papers by Yoko Ishii in
Google Scholar
PubMed
Search for other papers by Masakiyo Sasahara in
Google Scholar
PubMed
Search for other papers by Assaf Rudich in
Google Scholar
PubMed
Search for other papers by Takahiro Maeda in
Google Scholar
PubMed
Search for other papers by Tsutomu Wada in
Google Scholar
PubMed
Search for other papers by Toshiyasu Sasaoka in
Google Scholar
PubMed
Introduction The prevalence of lifestyle-related disorders, including insomnia, obesity and type 2 diabetes is increasing worldwide, mainly due to dramatic changes in living environments in modern society. Evidence indicates that environmental
Search for other papers by P Brandimarti in
Google Scholar
PubMed
Search for other papers by J M Costa-Júnior in
Google Scholar
PubMed
Search for other papers by S M Ferreira in
Google Scholar
PubMed
Search for other papers by A O Protzek in
Google Scholar
PubMed
Search for other papers by G J Santos in
Google Scholar
PubMed
Search for other papers by E M Carneiro in
Google Scholar
PubMed
Search for other papers by A C Boschero in
Google Scholar
PubMed
Search for other papers by L F Rezende in
Google Scholar
PubMed
Introduction Type 2 diabetes is a complex illness mainly characterized by hyperglycemia, usually accompanied by pancreatic islets malfunction, and reduced insulin sensitivity, as well as lower insulin clearance. Although hyperglycemia is one of the
Search for other papers by Paul Millar in
Google Scholar
PubMed
Search for other papers by Nupur Pathak in
Google Scholar
PubMed
Search for other papers by Vadivel Parthsarathy in
Google Scholar
PubMed
Search for other papers by Anthony J Bjourson in
Google Scholar
PubMed
Clinical Chemistry Laboratory, Western Health and Social Care Trust, Altnagelvin Hospital, Northern Ireland, UK
Search for other papers by Maurice O’Kane in
Google Scholar
PubMed
Search for other papers by Varun Pathak in
Google Scholar
PubMed
Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Search for other papers by Victor A Gault in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is a metabolic disorder that arises due to a complex array of molecular defects manifesting in dysregulated insulin secretion, impaired insulin action or both. Since the pathophysiology of T2DM is
Search for other papers by Mari van de Vyver in
Google Scholar
PubMed
. 2023 ). Figure 1 Factors contributing to chronic inflammation in type 2 diabetes. Continuous activation signals are derived from multiple sources including, dysfunctional adipose tissue, the aberrant metabolic activation of leukocytes, damage
Search for other papers by Vanesa Jiménez-Amilburu in
Google Scholar
PubMed
Search for other papers by Susanne Jong-Raadsen in
Google Scholar
PubMed
Search for other papers by Jeroen Bakkers in
Google Scholar
PubMed
Search for other papers by Herman P Spaink in
Google Scholar
PubMed
Search for other papers by Rubén Marín-Juez in
Google Scholar
PubMed
glycemic control present one of the main risk factors for developing heart failure ( Haslam & James 2005 ). Specially, type 2 diabetes (T2D) is strongly associated with heart failure ( Bell 2003 a ). Patients with T2D present an increased incidence of heart
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Search for other papers by Gary J Remington in
Google Scholar
PubMed
Search for other papers by Celine Teo in
Google Scholar
PubMed
Search for other papers by Virginia Wilson in
Google Scholar
PubMed
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Search for other papers by Araba Chintoh in
Google Scholar
PubMed
Search for other papers by Melanie Guenette in
Google Scholar
PubMed
Search for other papers by Zohra Ahsan in
Google Scholar
PubMed
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Search for other papers by Adria Giacca in
Google Scholar
PubMed
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Centre for Addiction and Mental Health, Institute of Medical Science, Department of Psychiatry, Department of Physiology, 250 College Street, Toronto, Ontario, Canada M5T 1R8
Search for other papers by Margaret K Hahn in
Google Scholar
PubMed
metabolic syndrome, dyslipidemias, weight gain and glucose dysmetabolism have been reported ( Goff et al . 2005 , Newcomer 2005 ). While weight gain associated with APs remains a major risk factor for type 2 diabetes (DM2) ( Pi-Sunyer 1993 ), there is
Search for other papers by Li Zhao in
Google Scholar
PubMed
Search for other papers by Chunfang Zhu in
Google Scholar
PubMed
Search for other papers by Meng Lu in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Xiaomin Nie in
Google Scholar
PubMed
Search for other papers by Buatikamu Abudukerimu in
Google Scholar
PubMed
Search for other papers by Kun Zhang in
Google Scholar
PubMed
Search for other papers by Zhiyuan Ning in
Google Scholar
PubMed
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Jing Cheng in
Google Scholar
PubMed
Search for other papers by Fangzhen Xia in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Michael D Jensen in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
Introduction Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder that is often associated with obesity, dyslipidemia, hypertension, microvascular disease and other complications ( American Diabetes Association 2016 ). All these
Search for other papers by Youichi Sato in
Google Scholar
PubMed
Search for other papers by Takanobu Kamada in
Google Scholar
PubMed
Search for other papers by Aiko Yamauchi in
Google Scholar
PubMed
Introduction Diabetes is a major worldwide public health problem ( Zimmet et al . 2001 ) that causes complications, such as retinopathy, nephropathy, neuropathy, dyslipidemia, and cardiovascular disease ( Crofford 1995 , Cannon 2008 , Srinivasan
Search for other papers by K Fosgerau in
Google Scholar
PubMed
Search for other papers by P Galle in
Google Scholar
PubMed
Search for other papers by T Hansen in
Google Scholar
PubMed
Search for other papers by A Albrechtsen in
Google Scholar
PubMed
Rheoscience, Department of Infectious Diseases, Department of Clinical Immunology, Department of International Health, Steno Diabetes Center, Faculty of Health Sciences, Department of In Vivo Pharmacology, 2730 Herlev, Denmark
Search for other papers by C de Lemos Rieper in
Google Scholar
PubMed
Search for other papers by B Klarlund Pedersen in
Google Scholar
PubMed
Search for other papers by L Kongskov Larsen in
Google Scholar
PubMed
Search for other papers by A Randrup Thomsen in
Google Scholar
PubMed
Rheoscience, Department of Infectious Diseases, Department of Clinical Immunology, Department of International Health, Steno Diabetes Center, Faculty of Health Sciences, Department of In Vivo Pharmacology, 2730 Herlev, Denmark
Search for other papers by O Pedersen in
Google Scholar
PubMed
Search for other papers by M Bagge Hansen in
Google Scholar
PubMed
Search for other papers by A Steensberg in
Google Scholar
PubMed
Introduction A complex interplay of pre- and post-natal environmental factors and polygenetics is involved in the pathogenesis of type 2 diabetes ( Andersen et al . 2005 ). Prominent pathological features include insulin resistance, inability in a